You are currently viewing February 2023
1 results showing for: 'ocrelizumab'
Inj 30 mg per ml, 10 ml vial
SA2051 - Ocrelizumab
- Brand Fully subsidised brand. Ocrevus
- Subsidy $9346.00
- Measure / Qty per 1
Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.
- Rectangle page icon symoblising a PDF. PDF
- A tick icon. Fully subsidised
- An oval with the number 29 in it. Unapproved medicine under Section 29
- An asterisk symbol. 3 or 6 months should be dispensed at once
- Two duplicate pages icon. Click to copy
- A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
- OP Original pack
- Sole Subsidised Supply
Email firstname.lastname@example.org to provide feedback: compliments, suggestions and complaints about the Online Pharmaceutical Schedule.